Washington, D.C. — House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) and Subcommittee on Oversight and Investigations Chair Morgan Griffith (R-VA) today announced a subcommittee hearing titled “Oversight of 340B Drug Pricing Program.” 

“It’s important that we preserve patients’ access to important and live-saving drugs. We must explore how the 340B program is working to ensure it aligns with how the program was intended to function,” said Chairs Rodgers and Griffith. “This hearing will give Members an opportunity to hear from industry experts about how the 340B program is working and, if necessary, how it could be improved.” 

Subcommittee on Oversight and Investigations hearing titled “Oversight of 340B Drug Pricing Program.”

WHAT: A subcommittee oversight hearing to learn about recent trends and developments in the 340B drug pricing program.

DATE: Tuesday, June 4, 2024

TIME: 10:30AM ET

LOCATION: 2322 Rayburn House Office Building

WITNESSES: Witnesses will be announced and are by invitation only.

This notice is at the direction of the Chair. The hearing will be open to the public and press and will be live streamed online at https://energycommerce.house.gov/. If you have any questions concerning the hearing, please contact Lauren Kennedy with the Committee staff at Lauren.Kennedy@mail.house.gov. If you have any press-related questions, please contact Christopher Krepich at Christopher.Krepich@mail.house.gov.